Company

Adiso Therapeutics

Biotechnology Research Concord, Massachusetts, United States 12 employees CVKD

Employees: 12
Contacts: 3
Emails: 3

adisotx.com LinkedIn Crunchbase

Adiso Therapeutics Overview

Headquarters: Concord, Massachusetts, United States
Website: adisotx.com
Industry: Biotechnology Research
Employees: 12
Founded: 2022
Stock Symbol: CVKD
Funding: 60.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Manager jobs

About Adiso Therapeutics

At Adiso, we create medicines to treat inflammatory diseases, improving the lives of patients and their families. Current treatment paradigms are far too often either inadequate to halt disease progression or burden the patient with significant safety concerns. To tackle these challenges, we are advancing an innovative pipeline of small molecules (ADS051 & ADS032) and single strain live biotherapeutic products (SS-LBP :: ADS024) both with novel mechanisms of action.

Adiso Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Adiso Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Dana Dexter		Marlborough, Massachusetts, United States	Email
Scott Megaffin	CEO, Board, Adiso Therapeutics	New York City Metropolitan Area, United States	Email
Andrew Peranick, Cfa	Sr. Director, Corporate Strategy and Business Development	New York City Metropolitan Area, United States	Email
Bharat Dixit		Greater Boston, United States	View